Biotech

All Articles

ArsenalBio increases $325M, pivots away from former lead possession

.Toolbox Biosciences is moving on up. The tissue treatment provider has added on $325 million in amm...

Lilly- backed weight management biotech reports IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana use medication flunks phase 2b, driving Indivior to review $100M possibility

.Aelis Farma's hopes of safeguarding a fast, favorable decision on a $100 million alternative paymen...

ProKidney stops phase 3 trial certainly not needed to have for cell treatment authorization

.ProKidney has quit one of a pair of period 3 trials for its own tissue therapy for kidney health co...

Vaxcyte climbs on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what experts called "magnificent" phase 1/2 information for its own 31-valent pneu...

Recursion's human brain disease test presents insufficient evidence of effectiveness

.Recursion has actually discovered via an early examination of its tech-enabled technique to drug di...

Acepodia, Pfizer click all together for chemistry-based tissue treatment

.Phone it a case of excellent chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy drug decreases seizures in period 2 litigation

.Practice Preciseness Medicines has scored yet another midphase gain in epilepsy this year, with its...

Three execs resign as Dyne blog posts mixed records for DMD applicant

.After running away a scientific hold numerous years back, Dyne Therapy has exposed new phase 1/2 in...

Arrowhead fires off stage 3 information in rare metabolic ailment before market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own give in front of a prospective face-off along with Ioni...